)
Aurora Cannabis (ACB) investor relations material
Aurora Cannabis Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved 7% year-over-year net revenue growth in Q3 FY26 to $94.2 million, led by a 12% increase in global medical cannabis revenue to $76.2 million and 17% international growth.
Adjusted EBITDA reached $18.5 million, adjusted net income was $7.2 million, and free cash flow was $15.5 million, supported by a strong cash position of $154.4 million and no cannabis business debt.
Over half of net revenue was generated outside Canada, reflecting global market leadership in medical cannabis, with top positions in Canada, Germany, Poland, the UK, and Australia.
Strategic focus is shifting to high-margin global medical cannabis, with exits from lower-margin consumer markets and restructuring of the plant propagation business.
Continued investment in science, genetics, and manufacturing to drive capacity, lower costs, and margin expansion.
Financial highlights
Q3 FY26 net revenue: $94.2 million, up 7% year-over-year; medical cannabis net revenue: $76.2 million, up 12%; international medical cannabis net revenue: $48 million, up 17%.
Consumer cannabis net revenue: $5.2 million, down 48% year-over-year; plant propagation net revenue: $11.3 million, up 27%.
Adjusted gross margin: 62% consolidated, with medical cannabis at 69% and consumer cannabis at 28%.
Adjusted EBITDA: $18.5 million, up 6% year-over-year; free cash flow: $15.5 million.
Cash and short-term investments: $154.4 million; no cannabis business debt, only non-recourse debt related to Bevo Farms.
Outlook and guidance
FY2026 global medical cannabis net revenue expected between $269 million and $281 million, driven by 10%-15% segment growth.
Annual consolidated adjusted EBITDA projected at $52–57 million, representing 5%-10% growth.
Adjusted gross margins expected to remain strong due to favorable sales mix and operational efficiencies.
Plant propagation revenue expected to follow seasonal trends, with most revenue in the first half of the year.
Continued focus on global medical cannabis leadership and expansion in emerging markets.
- TimeTickerHeadlineOpen
- 7 FebPGIL
Strong 9MFY26 growth with 13.2% higher revenue, margin gains, and upgraded credit ratings. - 7 Feb504614
Strong revenue and profit growth in Q3 FY26, led by power and steel segments. - 7 FebCHEMPLASTS
Net losses widened and revenue fell year-over-year amid regulatory and market headwinds. - 7 FebSBIN
Q3 FY26 net profit reached ₹21,028.15 crore, driven by robust income and strategic divestments. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus. - 6 FebWEC
Targets 7–8% EPS growth, $37.5B capex, and coal exit by 2032 amid surging data center demand. - 6 FebBR
Q2 FY26 recurring revenue grew 8% and adjusted EPS guidance was raised to 9-12%. - 6 FebFFWM
Merger vote includes new non-voting stock class with limited conversion and no voting rights. - 6 FebKKR
Charter amendments seek to modernize governance and establish one share, one vote by 2026.
Next Aurora Cannabis earnings date
Next Aurora Cannabis earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)